
GC38389
Evenamide
Also known as 2-[2-(3-butoxyphenyl)ethylamino]-N,N-dimethylacetamide
Evenamide (NW-3509) is an orally available voltage-gated sodium channel (VGSC) blocker (Ki=0·4 ?M) for the research of schizophrenia
ChemicalCAS1092977-61-1MW278.39FormulaC16H26N2O2
- CAS number
- 1092977-61-1
- Molecular weight
- 278.39
- Formula
- C16H26N2O2
- Solubility
- DMSO: 290 mg/mL (1041·70 mM)
- InChIKey
- GRHBODILPPXVKN-UHFFFAOYSA-N
- Catalogue number
- GC38389
- Brand
- GLPBIO
Computed properties PubChem CID 25105689 · XLogP 2.5 · TPSA 41.6 Ų · H-bond donors 1
- XLogP
- 2.5
- TPSA
- 41.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Rotatable bonds
- 9
- Heavy atoms
- 20
SMILES CCCCOC1=CC=CC(=C1)CCNCC(=O)N(C)C
Computed descriptors from PubChem (CID 25105689), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il